UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000030833 |
|---|---|
| Receipt number | R000035191 |
| Scientific Title | Examination of the immunity and the blood clotting in patients with advancer non-small cell lung cancer treated with bevacizumab.Accompaniment research of TORG1321 study (UMIN000010681) |
| Date of disclosure of the study information | 2018/01/16 |
| Last modified on | 2021/11/08 11:14:40 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/01/16 11:32:24 | ||
| 2 | Update | 2018/01/16 11:34:06 | Acronym Acronym |
|
| 3 | Update | 2020/07/13 16:46:18 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
| 4 | Update | 2020/11/05 11:44:48 | Recruitment status |
|
| 5 | Update | 2020/11/26 09:45:07 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 6 | Update | 2020/11/26 09:46:43 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 7 | Update | 2021/11/08 11:14:40 | Number of participants that the trial has enrolled |
